Coherent Corp. (COHR) stock analysis
Close on Nov 12, 2026Market cap $45.45BP/E 48.1Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed13 of 30 checks passed
Coherent passes 13 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 4/6
- Past performance
- 4/6
- Financial health
- 4/6
- Dividend
- 0/6
What stands out
Low debt
Debt is 35.3% of shareholders' equity, under the 40% we consider low.
Earnings grew over 5 years
Net income grew 22.0% a year on average over the last five fiscal years.
Revenue growing 10%+ a year
Revenue grew 11.3% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 286% over the last twelve months, against a 5-year average of 22.0% a year.
What to watch
Margin of safety under 20%
The price is 15.0% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $234.51 is above our fair value estimate of $203.84.
Return on equity under 15%
Return on equity was 11.2% over the last twelve months and averaged 1.6% over five years; we look for 15% on both.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals -1.5% of total debt; we look for at least 20%.
Valuation1/6
P/E below its 5-year median
Coherent's P/E of 48.7 is below its own 5-year median of 68.4.
P/E above the industry
Coherent's P/E of 48.7 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B above the industry
Coherent's price-to-book of 4.05 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading above fair value
The share price of $234.51 is above our fair value estimate of $203.84.
Margin of safety under 20%
The price is 15.0% above fair value, so there is no margin of safety.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 11.3% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth accelerating
Net income grew 286% over the last twelve months, against a 5-year average of 22.0% a year.
Growing faster than the industry
Revenue grew 30.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance issued
The latest outlook (first quarter of fiscal 2027 Revenue, Aug 12, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 38.2% over the last twelve months, against 35.8% a year earlier.
Past performance4/6
Return on equity under 15%
Return on equity was 11.2% over the last twelve months and averaged 1.6% over five years; we look for 15% on both.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
Coherent's return on equity of 11.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings grew over 5 years
Net income grew 22.0% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 12.2% over the last twelve months, against a 5-year average of 2.2%.
Net margin above the industry
Coherent's net margin of 12.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health4/6
Low debt
Debt is 35.3% of shareholders' equity, under the 40% we consider low.
Debt falling against equity
Debt to equity fell from 40.4% five years ago to 35.3%.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals -1.5% of total debt; we look for at least 20%.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 2.29 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.98; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Coherent has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$203.84
The share price is 15% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 45.0× | 68.4× | 36.5× | $216.90 | 80% |
| P/B | 2.6× | 2.1× | 3.2× | $151.61 | 20% |
| Fair value | $203.84 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 68.4
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $2.17B
- Value traded per 1% price move
- $455.59M
Downside
High risk
- Typical loss in a bad month
- 37.6%
- Volatility (annualized)
- 91%
- Sharpe ratio, 1 year
- 0.40
- Beta to the S&P 500 (5Y)
- 2.34
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +22.5% | +11.3% | +18.0% | +24.0% | |
| Gross profit | +30.6% | +18.1% | +17.8% | +23.9% | |
| Net income | +1530.7% | – | +22.0% | +28.5% | |
| EPS, diluted | – | – | +11.7% | +14.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 11.3% | 10.9% | 9.7% | |
| Return on assets | 7.1% | 5.1% | 4.8% | |
| Current ratio | 3.80 | 4.15 | 2.43 | |
| Debt to equity | 0.38 | 0.40 | 0.30 | |
| Net debt to EBITDA | 0.39× | -0.32× | – | |
| Interest coverage | 17.0× | 6.7× | – | |
| Inventory turnover | 3.1× | 2.9× | 2.2× | |
| Capex to revenue | 14.3% | 4.7% | 15.5% | |
| Diluted shares | 65M | 115M | 195M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Coherent generated $2.31B from operations and spent $2.64B on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | 11.3% | 0.43× | 2.01× | 9.7% |
| FY2025 | 0.8% | 0.40× | 2.71× | 0.9% |
| FY2024 | -3.3% | 0.33× | 2.77× | -3.1% |
| FY2023 | -5.0% | 0.48× | 2.51× | -6.0% |
| FY2022 | 7.1% | 0.46× | 2.04× | 6.7% |
| FY2021 | 9.6% | 0.53× | 2.14× | 10.9% |
| FY2020 | -2.8% | 0.66× | 2.24× | -4.2% |
| FY2019 | 7.9% | 0.73× | 1.72× | 10.0% |
| FY2018 | 7.6% | 0.72× | 1.68× | 9.1% |
| FY2017 | 9.8% | 0.72× | 1.60× | 11.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero$805.00M
- Cash generatingOperating cash flow above zero$79.51M
- Return on assets improvedROA up on the prior year0.3% → 5.4%
- Earnings backed by cashOperating cash flow above net income$79.51M vs $805.00M
- Less leverageLong-term debt to assets fell23.5% → 17.6%
- Better liquidityCurrent ratio rose2.19 → 2.43
- No dilutionShare count did not rise155M → 195M
- Gross margin improvedGross margin up on the prior year35.17% → 37.50%
- More efficientAsset turnover rose0.40 → 0.48
See a number that looks wrong?